Professional Documents
Culture Documents
"
! " # #ADA2021
Live Updates
02:02
The ADA will commemorate the centennial anniversary of the discovery of insulin at this year’s 81st
Scientific Sessions with a special symposium on Saturday, June 26. Modern giants in the field will
CLOSE
discuss the synthesis, secretion, and action of endogenous insulin, as well as its pharmacological
modifications and the future of insulin as therapy.
Learn More
READ MORE
Telemedicine and the ‘foot selfie’ helped providers deliver diabetic foot
care during the pandemic
Brian M. Schmidt, DPM, and Laura Shin, DPM, PhD, shared
strategies used to maintain access to care and regular physical
exams for patients with diabetic foot complications amid COVID-
#1
19.
INITIATED BRANDED
TYPE 2 DIABETES
TREATMENT*
*Among new prescriptions as measured by new-to-brand
prescriptions through 03/07/2021.
READ MORE
FOR ADULTS WITH TYPE 2 DIABETES,
ALONG WITH DIET AND EXERCISE
see more like this
Choose JARDIANCE as your first
add-on to metformin.
@ADA_DIABETESPRO
Session Coverage 8:00 pm | June 25, 2021
Beyond carb counting: Emerging technology offers new insights into the
dynamics of macronutrients and blood glucose
“You could eat a diet of bacon and diet soda all day long and you’d
manage your glucose really well. But that wouldn’t be good for
your whole health,” said Holly Willis, PhD, RDN, LD.
READ MORE
diaTribe @diaTribeNews
Have you ever attended a session at ADA scientific sessions
that you do not want to end? We have. #ADA2021
Lisa S. Chow, MD, MS, serves as chair for a symposium that addresses the timing of food intake and
fasting, drug metabolism, and more. View this session at ADA2021.org. Lisa S. Chow, MD, MS, serves as
chair for a symposium that addresses the timing of food intake and fasting, drug metabolism, and
more. View this session at ADA2021.org.
Assistir no
Robert Gabbay, MD, PhD, ADA Chief Scientific and Medical Officer, outlines how the COVID-19
pandemic has served as an accelerant of change for the ADA and the health care community.
Weighing the costs vs. benefits of SGLT2 inhibitors and GLP-1 receptor
agonists
In a symposium beginning at 4:15 p.m. ET, Hui Shao, MD, PhD, will
discuss the financial implications on the health care system
brought by these classes of agents, which have transformed
diabetes care for individuals who also have cardiovascular disease.
READ MORE
Watch it now: The Expanded Scope of the Diabetes Care and Education
Specialist
Nancy D’Hondt, RPh, CDCES, FADCES, is the chair of a symposium on the expanded role of a key
member of the diabetes care team. View this session at ADA2021.org.
A symposium chaired by David A. Baidal, MD, highlights the complexities of mental health disorders in
people with diabetes. View this session at ADA2021.org.
Tom Crabtree
@TomCrabtree90
Starting soon: Experts will discuss the impact of social justice issues on
vulnerable diabetes patient populations
Shivani Agarwal, MD, MPH, Shakira Suglia, ScD, MS, and J. Frank
Wharam, MD, MPH, will examine strategies to address risks
influenced by social needs and to improve outcomes in a session
beginning at 2:00 p.m. ET.
READ MORE
Live Q&A starting soon: Influence of Social Inequalities and Social Stress
on Metabolic Health
Alessandro Bartolomucci, PhD, is the chair of a mini-symposium taking place now on the influence of
social inequalities and social stress on metabolic health that includes a live video question and
answer period starting at 1:25 p.m. ET. This discussion will be available for viewing with the on-
demand session recording at ADA2021.org within 24 hours.
READ MORE
READ MORE
READ MORE
Starting soon: Experts will explain how viruses, including COVID-19, affect
pediatric diabetes risk
“The relationship between viruses, genetic background, and the
immune system are all involved in this autoimmune process that
leads to disease,” explained epidemiologist Kendra Vehik, PhD,
MPH, one of the featured speakers for a mini-symposium starting
at 12:45 p.m. ET.
READ MORE
READ MORE
READ MORE
Live Q&A starting soon: Intersection of Diabetes, Heart Failure, and Kidney
Disease—Challenges and New Insights
Sanjay Kaul, MD, FACC, FAHA, is the chair of a mini-symposium taking place now on the intersection of
diabetes, heart failure, and kidney disease. The session includes a live video question and answer
period starting at 12:15 p.m. ET. This discussion will be available for viewing with the on-demand
session recording at ADA2021.org within 24 hours.
READ MORE